Previous studies investigating the limitations of conventional AUD treatment highlight that the primary barrier to pharmacological efficacy is the need for intensive behavioral engagement, which has been frequently observed to hinder long-term adherence
However, life-changing doesn't mean risk-free
All refer to semaglutide-based medications
For many women, this transitional phase brings a whirlwind of changes hormonal fluctuations, emotional highs and lows, sleep disturbances, and various physical symptoms that disrupt daily life
What The Study Found Patients taking GLP-1 drugs had: Fewer complications after kidney surgery Less kidney damage Fewer heart rhythm problems Fewer hospital readmissions Even more surprising: Patients taking GLP-1 drugs lived longer when followed up 23 years after surgery than patients not taking these drugs
doi: 10.1073/pnas.0906112107